Aga Khan University Hospitals in Karachi, Pakistan and Nairobi, Kenya are private, not-for-profit institutions providing high quality health care. The...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - AUMANUFACTURING.COM.AU - A La Une - 26/Jun 14:41
2nd generation bionic eye tests ‘encouraging’
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years. Detailed outcomes from the trial, led by the Centre for Eye Research Australia, Bionics Institute, University of… The post 2nd generation bionic eye tests ‘encouraging’ appeared first on Australian Manufacturing Forum.
Articles similaires
Enhanced Fertility Outcomes With OXO-001 in IVF
medindia.net - 18:32
New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug OXO-001 in increasing embryo implantation,...
Cytel - USA & APAC: Vice President, Innovative Clinical Trial Designs
pharmiweb.com - 00:00
Competitive: Cytel - USA & APAC: Executive Consultant - Innovative Designs As a leader in next generation, data-driven pharmaceutical services, Cytel...
Approval for the First Dose Cohort in Phase 1a/b Clinical Trial of PMC-309 in Patients with Advanced or Metastatic Solid Tumors
drugs.com - 00:07
DAEJEON, South Korea, July 8, 2024. PharmAbcine Inc., a clinical-stage biotech company focusing on next-generation antibody therapeutics, announced...
Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial
zacks.com - 05/Jul 15:48
Microbot Medical's (MBOT) LIBERTY Endovascular Robotic System trial expands to Baptist Hospital of Miami, promising advancements in clinical outcomes...
Cartesian Therapeutics doses first patient in phase 2 clinical trial of Descartes─08 to treat systematic lupus erythematosus
pharmabiz.com - 04/Jul 00:00
Cartesian Therapeutics, Inc, a clinical─stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that the first...
NATO Is Not Ready For War: Assessing Military Balance Between The Alliance And Russia – Analysis
eurasiareview.com - 01/Jul 23:29
By Can Kasapoğlu Part 1: Assessing the Russian Geopolitical Threat to NATO The Russian Military Is Prepared for a Long War Through his...
Scientists map all the possible outcomes of changes to key tumor-suppressing gene
news.medical.net - 05/Jul 16:40
Researchers at the Francis Crick Institute have mapped all the possible outcomes of changes to a tumor-suppressing gene called VHL, the first step in...
Pure Hydrogen garbage truck for Newcastle
aumanufacturing.com.au - 27/Jun 15:02
Clean energy and mobility company Pure Hydrogen is to supply a rear-loading hydrogen fuel cell (HFC) waste collection vehicle to the City of...
Les derniers communiqués
-
Aucun élément